SML3702
Testosterone cypionate
≥98% (HPLC)
Synonym(s):
(17β)-17-(3-Cyclopentyl-1-oxopropoxy)androst-4-en-3-one, 17β-Hydroxyandrost-4-en-3-one cyclopentylpropionate, Cyclopentanepropionic acid ester with testosterone, NSC 9157
Sign In to View Organizational & Contract Pricing.
Select a Size
About This Item
Empirical Formula (Hill Notation):
C27H40O3
CAS Number:
Molecular Weight:
412.60
UNSPSC Code:
12352200
NACRES:
NA.24
MDL number:
assay
≥98% (HPLC)
form
powder
drug control
USDEA Schedule III
color
white to beige
solubility
DMSO: 2 mg/mL, clear (Warmed)
storage temp.
2-8°C
Quality Level
Related Categories
Biochem/physiol Actions
Orally available prodrug of testosterone that has a long elimination half-life; androgen that acts as agonist of the androgen receptor (AR)
Testosterone cypionate is a prodrug of testosterone that has a long elimination half-life. It is an androgen and anabolic–androgenic steroid that acts as agonist of the androgen receptor (AR). Testosterone cypionate is mainly used in the treatment of low testosterone levels in men. Also, it was approved for treatment of hypogonadism.
signalword
Warning
hcodes
Hazard Classifications
Acute Tox. 4 Oral - Aquatic Acute 1 - Aquatic Chronic 1 - Carc. 2 - Repr. 2
Storage Class
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Regulatory Information
新产品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Pharmacology of testosterone replacement therapy preparations
Translational andrology and urology, 5(6), 834-843 (2016)
Modulation of inflammatory and hormonal parameters in response to testosterone therapy: Effects on the ventral prostate of adult rats
Cell Biology International, 42(9), 1200-1211 (2018)
Durable Response of Enzalutamide-resistant Prostate Cancer to Supraphysiological Testosterone Is Associated with a Multifaceted Growth Suppression and Impaired DNA Damage Response Transcriptomic Program in Patient-derived Xenografts
European Urology, 77(2), 144-155 (2020)
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service